We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$23.9B
AUM Growth
+$1.07B
Cap. Flow
-$810M
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.29%
Holding
2,206
New
135
Increased
803
Reduced
603
Closed
151

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$50M
2
TFC icon
Truist Financial
TFC
+$40.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$39M
4
BSX icon
Boston Scientific
BSX
+$32.9M
5
CAT icon
Caterpillar
CAT
+$32.7M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$107M
2
CELG
Celgene Corp
CELG
+$54.9M
3
PANW icon
Palo Alto Networks
PANW
+$50.1M
4
TAP icon
Molson Coors Class B
TAP
+$46.6M
5
AAPL icon
Apple
AAPL
+$44.7M

Sector Composition

Rank Sector Weight
1 Technology 20.2%
2 Financials 16.88%
3 Healthcare 13.3%
4 Communication Services 9.11%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVL
1951
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$30K ﹤0.01%
1,900
– –
TWST icon
1952
Twist Bioscience
TWST
$5.62B
$29K ﹤0.01%
1,400
– –
AKRO
1953
DELISTED
Akero Therapeutics
AKRO
$28K ﹤0.01%
1,300
– –
UNT
1954
DELISTED
UNIT Corporation
UNT
$28K ﹤0.01%
41,000
– –
VRCA icon
1955
Verrica Pharmaceuticals
VRCA
$86.2M
$27K ﹤0.01%
170
– –
KRRO icon
1956
Korro Bio
KRRO
$153M
$26K ﹤0.01%
+30
New +$23.3K
BCEL
1957
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$26K ﹤0.01%
1,700
– –
CBNK icon
1958
Capital Bancorp
CBNK
$588M
$25K ﹤0.01%
1,700
– –
KTB icon
1959
Kontoor Brands
KTB
$4.62B
$25K ﹤0.01%
609
– –
NODK icon
1960
NI Holdings
NODK
$325M
$25K ﹤0.01%
1,500
– –
CABA icon
1961
Cabaletta Bio
CABA
$439M
$23K ﹤0.01%
+1,700
New +$20.1K
KVHI icon
1962
KVH Industries
KVHI
$177M
$23K ﹤0.01%
2,100
-3,400
-62% -$36.1K
VIR icon
1963
Vir Biotechnology
VIR
$1.47B
$23K ﹤0.01%
+1,900
New +$25.5K
EVFM
1964
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$23K ﹤0.01%
253
– –
BDC icon
1965
Belden
BDC
$4B
$22K ﹤0.01%
400
-52,500
-99% -$2.8M
XGN icon
1966
Exagen
XGN
$113M
$22K ﹤0.01%
+900
New +$16K
MORF
1967
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$22K ﹤0.01%
1,300
– –
ELOX
1968
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$22K ﹤0.01%
78
– –
PHAS
1969
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$22K ﹤0.01%
3,700
– –
BXRX
1970
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$22K ﹤0.01%
+2
New +$17.1K
ROSE
1971
DELISTED
Rosehill Resources Inc. Class A
ROSE
$22K ﹤0.01%
17,300
– –
ETNB
1972
DELISTED
89bio
ETNB
$21K ﹤0.01%
+800
New +$22.3K
FMNB icon
1973
Farmers National Banc Corp
FMNB
$899M
$21K ﹤0.01%
1,300
– –
RMNI icon
1974
Rimini Street
RMNI
$408M
$21K ﹤0.01%
5,500
– –
STSA
1975
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$21K ﹤0.01%
+1,100
New +$15.6K
77 78
79
80 81

Similar funds

Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

STRS Ohio's Q4 2019 Portfolio in Review

As of Q4 2019, STRS Ohio held 2,206 positions worth $23.9B, up 4.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

STRS Ohio withdrew a net $810M in Q4 2019, closing 151 positions and reducing 603 holdings. Its most notable exit was Celgene Corp, an estimated $54.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, STRS Ohio opened a new position in Everpure Inc worth $10.4M.

  • STRS Ohio's largest Q4 2019 buy was Everpure Inc: 607,721 shares worth $10.4M.
  • STRS Ohio added most to Johnson & Johnson in Q4 2019, an estimated $50M increase.
  • STRS Ohio's biggest Q4 2019 reduction was iShares MSCI EAFE ETF, cutting an estimated $107M.
  • STRS Ohio fully exited Celgene Corp in Q4 2019, selling an estimated $54.9M.
  • STRS Ohio's ten largest holdings make up 19% of its $23.9B portfolio in Q4 2019.
  • STRS Ohio opened 135 new positions and closed 151 in Q4 2019.
  • STRS Ohio's portfolio value rose 4.7% quarter-over-quarter to $23.9B.

Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.